v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
At-the-Market Public Offering [Member]
Private Placement [Member]
Common Stock [Member]
Common Stock [Member]
At-the-Market Public Offering [Member]
Common Stock [Member]
Private Placement [Member]
Additional Paid in Capital [Member]
Additional Paid in Capital [Member]
At-the-Market Public Offering [Member]
Additional Paid in Capital [Member]
Private Placement [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2024 $ 137,246     $ 40     $ 920,609     $ 47 $ (783,450)
Beginning balance, units at Dec. 31, 2024       40,468,141              
Issuance of common stock, net of issuance costs 135,367 $ 246   $ 36     135,331 $ 246      
Issuance of common stock, net of issuance costs, units       35,739,810 61,542            
Issuance of pre-funded warrants in public offering/private placement 52,590           52,590        
Issuance of common stock in private placement for payment of developmental milestone consideration 5,000     $ 1     4,999        
Issuance of common stock in private placement for payment of developmental milestone consideration, units       975,496              
Vesting of restricted stock, units       247,970              
Unrealized loss on available-for-sale securities (45)                 (45)  
Equity-based compensation expense 3,341           3,341        
Net loss (39,282)                   (39,282)
Ending balance at Mar. 31, 2025 294,463     $ 77     1,117,116     2 (822,732)
Ending balance, units at Mar. 31, 2025       77,492,959              
Beginning balance at Dec. 31, 2025 180,010     $ 79     1,137,654     52 (957,775)
Beginning balance, units at Dec. 31, 2025       78,967,888              
Issuance of common stock, net of issuance costs   $ 11,927 $ 79,224   $ 2 $ 15   $ 11,925 $ 79,209    
Issuance of common stock, net of issuance costs, units         1,937,623 14,973,257          
Issuance of pre-funded warrants in public offering/private placement 147,104           147,104        
Issuance of common stock in private placement for payment of developmental milestone consideration 7,500     $ 1     7,499        
Issuance of common stock in private placement for payment of developmental milestone consideration, units       1,316,899              
Vesting of restricted and performance stock units       $ 1     (1)        
Vesting of restricted and performance stock, units       1,193,931              
Exercises of common stock options $ 17           17        
Exercises of common stock options, units 5,122     5,122              
Unrealized loss on available-for-sale securities $ (65)                 (65)  
Equity-based compensation expense 5,152           5,152        
Net loss (56,737)                   (56,737)
Ending balance at Mar. 31, 2026 $ 374,132     $ 98     $ 1,388,559     $ (13) $ (1,014,512)
Ending balance, units at Mar. 31, 2026       98,394,720